Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannabix Technologies Inc C.BLO

Alternate Symbol(s):  BLOZF

Technology Scientific & Technical Instruments Cannabis
Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Company’s primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.


CSE:BLO - Post by User

Cannabix Technologies Inc > BLO RECEIVED ALLOWANCE FOR ITS PATENT!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by Humaniston Oct 28, 2020 9:15am
441 Views
Post# 31794556

BLO RECEIVED ALLOWANCE FOR ITS PATENT!

BLO RECEIVED ALLOWANCE FOR ITS PATENT!Cannabix Technologies Receives Notice of Allowance for Cannabis Drug Detection Device U.S. Patent

by @nasdaq on 28 Oct 2020, 08:45
    
VANCOUVER, British Columbia, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its 2015 licensed patent application, No. 14/689434 entitled, “Cannabis Drug Detection Device”. The Company and its patent attorneys have been vigorously pursuing this original patent application since its filing in the spring of 2015. It should be noted that a notice of allowance from the USPTO does not constitute a grant of patent. The Company will report on future material developments regarding its “Cannabis Drug Detection Device” patent application in due course.

Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (“THC”) - the psychoactive component of marijuana that causes impairment.

About Cannabix Technologies Inc.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities